Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
Total neoadjuvant therapy for rectal cancer: evidence and challenge
Ann Coloproctol. 2023 Aug;39(4):301-306. doi: 10.3393/ac.2023.00269.0038. Epub 2023 Aug 29.ABSTRACTRecent advances in the management of rectal cancer have dramatically changed the clinical practice of colorectal surgeons because the main focus of rectal cancer treatment has changed from sphincter-saving to an organ-preserving strategies. Modifying the delivery of systemic chemotherapy to improve patients' survival is another progress in colorectal cancer management, known as total neoadjuvant therapy (TNT). TNT is a new strategy used by colorectal surgeons to improve the quality of life and survival of patients after treat...
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Suk-Hwan Lee Source Type: research
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
Total neoadjuvant therapy for rectal cancer: evidence and challenge
Ann Coloproctol. 2023 Aug;39(4):301-306. doi: 10.3393/ac.2023.00269.0038. Epub 2023 Aug 29.ABSTRACTRecent advances in the management of rectal cancer have dramatically changed the clinical practice of colorectal surgeons because the main focus of rectal cancer treatment has changed from sphincter-saving to an organ-preserving strategies. Modifying the delivery of systemic chemotherapy to improve patients' survival is another progress in colorectal cancer management, known as total neoadjuvant therapy (TNT). TNT is a new strategy used by colorectal surgeons to improve the quality of life and survival of patients after treat...
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Suk-Hwan Lee Source Type: research
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
Total neoadjuvant therapy for rectal cancer: evidence and challenge
Ann Coloproctol. 2023 Aug;39(4):301-306. doi: 10.3393/ac.2023.00269.0038. Epub 2023 Aug 29.ABSTRACTRecent advances in the management of rectal cancer have dramatically changed the clinical practice of colorectal surgeons because the main focus of rectal cancer treatment has changed from sphincter-saving to an organ-preserving strategies. Modifying the delivery of systemic chemotherapy to improve patients' survival is another progress in colorectal cancer management, known as total neoadjuvant therapy (TNT). TNT is a new strategy used by colorectal surgeons to improve the quality of life and survival of patients after treat...
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Suk-Hwan Lee Source Type: research
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
Total neoadjuvant therapy for rectal cancer: evidence and challenge
Ann Coloproctol. 2023 Aug;39(4):301-306. doi: 10.3393/ac.2023.00269.0038. Epub 2023 Aug 29.ABSTRACTRecent advances in the management of rectal cancer have dramatically changed the clinical practice of colorectal surgeons because the main focus of rectal cancer treatment has changed from sphincter-saving to an organ-preserving strategies. Modifying the delivery of systemic chemotherapy to improve patients' survival is another progress in colorectal cancer management, known as total neoadjuvant therapy (TNT). TNT is a new strategy used by colorectal surgeons to improve the quality of life and survival of patients after treat...
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Suk-Hwan Lee Source Type: research
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
Total neoadjuvant therapy for rectal cancer: evidence and challenge
Ann Coloproctol. 2023 Aug;39(4):301-306. doi: 10.3393/ac.2023.00269.0038. Epub 2023 Aug 29.ABSTRACTRecent advances in the management of rectal cancer have dramatically changed the clinical practice of colorectal surgeons because the main focus of rectal cancer treatment has changed from sphincter-saving to an organ-preserving strategies. Modifying the delivery of systemic chemotherapy to improve patients' survival is another progress in colorectal cancer management, known as total neoadjuvant therapy (TNT). TNT is a new strategy used by colorectal surgeons to improve the quality of life and survival of patients after treat...
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Suk-Hwan Lee Source Type: research
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Ann Coloproctol. 2023 Aug;39(4):287-288. doi: 10.3393/ac.2023.00486.0069. Epub 2023 Aug 29.NO ABSTRACTPMID:37648422 | PMC:PMC10475799 | DOI:10.3393/ac.2023.00486.0069 (Source: Annals of Coloproctology)
Source: Annals of Coloproctology - August 30, 2023 Category: Gastroenterology Authors: Chul Seung Lee Source Type: research
